Ma

mAbs

mAbs is a multidisciplinary open access journal dedicated to antibody research and development. It covers topics including engineering and selection of antibody therapeutics, machine learning and artificial intelligence applications, non-clinical antibody studies, manufacturing and formulation, regulatory review of antibody therapeutics, and post-approval market topics, and serves scientific, medical, technology transfer, legal, investment, planning, and therapeutics regulation audiences.

Looking to publish in mAbs? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.

Existing customer login
Subject Medicine, Research & Experimental
Impact Factor 7.3
Quartile Q1
Open Access Type Hybrid
ISSN 1942-0862
eISSN 1942-0870
Invitation Only No
Cost Range Open access publication may be covered by an institutional open access agreement; specific APC amounts are not stated.

Submission Instructions

mAbs accepts the following article types. Click on an article type to view submission instructions.

Research Articles

Cover Letter Cover Letter requirements are not specified.
Abstract A single-paragraph abstract is required for Research Articles. The abstract must be fewer than 250 words. The abstract must be unstructured as a single paragraph.
Manuscript Research Articles must include Introduction, Patients and Methods or Materials and Methods, Results, and Discussion sections. Manuscripts must include 5 to 10 keywords, a disclosure statement under the subheading “Disclosure of interest,” and figure legends.
References Research Articles must include no more than 85 references. References may be in any consistent scholarly citation style or format. Bibliographic entries must include author name(s), source title, article or chapter title, year, volume and issue where appropriate, page numbers, and a corresponding in-text citation.
Figures & Tables Figures and tables may be placed within the text or submitted as separate documents. Tables must be numbered consecutively with Arabic numerals and include descriptive titles and legends.
Reformat to mAbs using Livewrite Premium

Reviews

Cover Letter Cover Letter requirements are not specified.
Abstract An abstract is required. Abstract must be 150 words.
Manuscript The opening paragraph must explain the review’s general thrust and timeliness, and the concluding paragraph must discuss future developments or problems rather than summarize the article. The manuscript must include 5–10 keywords for indexing purposes.
References Reviews must cite no more than 150 references. References may be in any style or format if a consistent scholarly citation format is used. Bibliographic entries must include the author name(s), article or chapter title, journal or book title, year, volume and issue where appropriate, page numbers, and a corresponding in-text citation.
Figures & Tables Figures and tables may be placed within the text or submitted as separate documents.
Reformat to mAbs using Livewrite Premium

Brief Reports

Cover Letter Cover Letter requirements are not specified.
Abstract A one-paragraph abstract is required for Brief Reports. Abstract must be fewer than 150 words. Abstract must be unstructured as a single paragraph.
Manuscript Manuscripts must include 5 to 10 keywords, a disclosure statement under the subheading “Disclosure of interest,” and a word count for the paper.
References References may be in any style or format if a consistent scholarly citation format is used. References must include complete bibliographic details and each entry must have a corresponding in-text citation.
Figures & Tables Figures and tables may be placed within the text or submitted as separate documents.
Reformat to mAbs using Livewrite Premium

Short Communications

Cover Letter Cover Letter requirements are not specified.
Abstract An abstract is required for Short Communications. Abstract must not exceed 120 words. Abstract structure is not specified.
Manuscript Manuscript must not exceed 4,500 words in total. Short Communications must follow the structure of a Research Article but without headings or subheadings. Manuscript must include 5 to 10 keywords and a disclosure statement under the subheading “Disclosure of interest.”
References Short Communications must include no more than 50 references. References may be submitted in any consistent scholarly citation style or format. Bibliographic entries must include the relevant publication details and each entry must have a corresponding in-text citation.
Figures & Tables Figures and tables may be embedded within the text or submitted as separate documents.
Reformat to mAbs using Livewrite Premium

Recent Publications

Optimization strategies for monoclonal antibody production: advances in simulation and artificial intelligence in bioprocessing

Kadeejathul Kubra, Munawar A. Shaik

10.1080/19420862.2026.2706886
View Publication

Conditional activation of IL-12 through a Fibronectin-EDB dependent switch gate

Josephine D. Kahn, Kothai Parthiban, Peter Slavny, Aaron Arvey, Marc Presler, Jamie Nosbisch, Adrienne Rothschilds, Allan Capili, Teresa Barata, Joana Martins, Jiang Zhu, Robert Kamen, Robert Tepper, Ton N. Schumacher, Lioudmila Tchistiakova, Divya Mathur

10.1080/19420862.2026.2700812
View Publication

Glycosylation penetrance of N-X-S/T sequons in antibody variable domains: a structural survey of 19,265 human antibody structures reassessing the histidine/glutamine suppression hypothesis

Christopher L. Gaughan

10.1080/19420862.2026.2703349
View Publication

A NANOBODY molecule that blocks MerTK ectodomain cleavage in vitro and in vivo

Linde Duprez, Ayse Kilic, Hélène Bruwiere, Karim Fekir, Dennis Vlaeminck, Camille De Craene, Daan Geiregat, Kirsten Paesen, Lien Leutenez, Stijn Lambrecht, Thomas Van De Velde, Aline Moliere, Judith Verhelst, Edith Stuyven, Soraya Hoelper, Dieter Schmoll

10.1080/19420862.2026.2704449
View Publication

Setting expectations for current and future directions of native mass spectrometry in the biopharmaceutical industry

Elizabeth Hecht, Esther Martin, Idlir Liko, Andrew Mahan, Aniruddha Sahasrabuddhe, Nastaran N. Tajoddin, Iain D. G. Campuzano

10.1080/19420862.2026.2699078
View Publication

Frequently asked questions

How long does it take to publish?

13 days average from submission to first decision; 27 days average from submission to first post-review decision; 11 days average from acceptance to online publication.

Reformat to mAbs using Livewrite Premium

What are the publication costs?

Open access publication may be covered by an institutional open access agreement; specific APC amounts are not stated.

Reformat to mAbs using Livewrite Premium

Research Topics

Monoclonal and Polyclonal Antibodies Research Protein purification and stability Glycosylation and Glycoproteins Research Viral Infectious Diseases and Gene Expression in Insects Biosimilars and Bioanalytical Methods CAR-T cell therapy research T-cell and B-cell Immunology HER2/EGFR in Cancer Research Immunotherapy and Immune Responses Immune Cell Function and Interaction Transgenic Plants and Applications Chronic Lymphocytic Leukemia Research vaccines and immunoinformatics approaches Galectins and Cancer Biology Toxin Mechanisms and Immunotoxins Advanced Biosensing Techniques and Applications Cell Adhesion Molecules Research Immunodeficiency and Autoimmune Disorders Cancer Immunotherapy and Biomarkers SARS-CoV-2 and COVID-19 Research Complement system in diseases Mass Spectrometry Techniques and Applications Peptidase Inhibition and Analysis Lymphoma Diagnosis and Treatment Nanofabrication and Lithography Techniques

Related Journals

MG
Medical Gas Research Medknow
JO
Journal of Biomedical Science BioMed Central
Eb
EBioMedicine Elsevier BV
CT
Cell Transplantation SAGE Publishing
AI
Advances in Therapy Adis, Springer Healthcare
MT
Molecular Therapy Oncology CELL PRESS